IRIS
ARVIGO, MARICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.532
AS - Asia 20
SA - Sud America 12
Totale 6.564
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.532
CN - Cina 12
BR - Brasile 8
VN - Vietnam 5
AR - Argentina 3
SG - Singapore 2
ID - Indonesia 1
VE - Venezuela 1
Totale 6.564
Salva come PNG Salva come JPEG
Città #
Genova 4.072
Genoa 1.522
Rapallo 526
Vado Ligure 405
Beijing 5
Bordighera 4
Ho Chi Minh City 3
Rome 3
Aquidabã 1
Boa Vista 1
Capitán Bermúdez 1
Carapicuíba 1
Caxias do Sul 1
Chacabuco 1
Hanoi 1
Huế 1
Jaboatão dos Guararapes 1
Merlo 1
Oeiras 1
Pelotas 1
Pinhais 1
San Cristóbal 1
Surabaya 1
Totale 6.555
Salva come PNG Salva come JPEG
Nome #
Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins 284
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES 196
Effect of environment on growth: auxological and hormonal parameters in African and Italian children 190
Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells 178
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology 168
Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture 163
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases 162
Somatostatin-induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, protein kinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings. 156
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth. 156
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 156
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation 152
Pancreatic Islet Cell Tumor Secreting Insulin-Like Growth Factor Type-II in a Dog. 149
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 148
Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with turner's syndrome in culture 146
Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit of the 150 kDa complex by rat hepatocyte in primary culture. 146
Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I. J.Clin.Endocrinol.Metab. 80 (4):1318-1324, 1995. 144
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms 143
Canine pancreatic islet cell tumours secreting insulin-like growth factor type 2: A rare entity 141
Paraneoplastic hypoglycemia due to an insulin-like growth factor type-II secreting hepatocellular carcinoma in a dog. 140
Somatostatin receptor scintigraphy in thoracic diseases 137
Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily 135
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 135
P68 Insulin-like growth factor (IGF) binding protein-3 inhibits IGF-II-stimulated IRS-1/PI-3-kinase activity and cell growth in human non-small cell lung cancer (NSCLC) cell lines 128
Role of adiponectin and leptin on body development in infants during the first year of life 128
Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database 125
Interrelationships between follicle stimulating hormone and the growth hormone--insulin-like growth factor--IGF-binding proteins axes in human granulosa cells in culture 122
In memory of Francesco Maria Minuto. 121
OR2,6 Interrelationship between somatostatin/dopamine pathways and growth factors in non-small lung cancer cells 119
Regulation Of Prostate Cancer Cell Proliferation By Somatostatin Receptor Activation 118
Dopamine receptor expression and function in corticotroph pituitary tumors. 117
Effect of octreotide on circulating IGF-I chromatographic profile: evidence for an inhibitory action on the formation of the 150-kDa ternary complex 116
Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro. 115
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 114
Novel chimeric somatostatin analogs: facts and perspectives 112
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 111
Ten years of gastroeneteropancreatic neuroendocrine tumors: is reclassification Worth while? 111
null 110
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study. 109
Role of somatostatin analogues in the management of immunolymphoproliferative diseases 108
IGF-I production by adult rat hepatocytes is stimulated by transforming growth factor alfa and trasforming growth factor beta1 107
Octreotide and pasireotide combination treatment in somatotroph tumor cells: Predominant role of sst2 in mediating ligand effects 103
Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1beta in vitro 102
The IGF system and bone 99
Abstracts of the 6th Annual ENETS Conference, Granada, Spain, March 5–7, 2009 97
Somatostatin, somatostatin analogs and somatostatin receptor dynamics in the biology of cancer progression. 92
Serum IGF-I concentration is positively associated with 25-hydroxyvitamin D level and increases upon treatment with vitamin D. 89
Rationale for treating cancer with somatostatin analogs. 88
Corrigendum to "Regulation of prostate cancer cell proliferation by somatostatin receptor activation" [Mol. Cell. Endocrinol. 315 (1-2) (2010) 254-262] 56
Differential Impact of Medical Therapies for Acromegaly on Glucose Metabolism 56
The role of somatostatin analogs in the management of immunoproliferative disease 51
β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids 50
Potential indications for somatostatin analogues: immune system and limphoproliferative disorders 45
Somatostatin receptor expression and patients' response to targeted medical treatment in pituitary tumors: evidences and controversies. 40
Digital quantification of somatostatin receptor subtypes 2 and 5 in growth hormone–secreting pituitary tumors 34
Somatostatin receptor pathophysiology in the neuroendocrine system 11
Totale 6.629
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.705
article - articoli 20.452
book - libri 0
conference - conferenze 253
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.410
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021370 0 0 0 126 30 24 7 44 26 56 30 27
2021/2022667 14 44 65 91 18 40 32 148 34 58 28 95
2022/2023622 58 62 7 70 79 101 0 50 96 5 90 4
2023/2024307 18 38 4 49 18 48 23 12 13 5 38 41
2024/20251.055 36 75 30 55 136 99 118 180 34 36 108 148
2025/2026524 236 47 94 147 0 0 0 0 0 0 0 0
Totale 6.629